Sartorius Stedim Biotech's total assets for Q3 2025 were €7.88B, a decrease of -5.21% from the previous quarter. FR:DIM total liabilities were €3.81B for the fiscal quarter, a -10.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.